Home > Analytics > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Intrinsic Value | Fundamental Analysis

BOM : 524663     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Nov 19,2024
Price(EOD): ₹ 23.78
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 102.73 Cr
Value of ₹ 1 Lac invested in BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
on Nov 20,2019 (price: ₹ 8.48)

₹ 1 L

₹ 2.80 L

1W : -4.2% 1M : -9.9% 1Y : -3.7%
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION -4.2% -9.9% -3.7%
SUN PHARMACEUTICAL INDUSTRIES -1.4% -7.1% 48%
CIPLA -3.5% -5.2% 18%
DR REDDYS LABORATORIES -3.9% -10.1% 10.1%
ZYDUS LIFESCIENCES -0.3% -7.3% 52.2%
DIVIS LABORATORIES 1.5% -2.1% 63%
MANKIND PHARMA -2.3% -3% 39.6%
TORRENT PHARMACEUTICALS -1.8% -10.2% 51.3%
LUPIN -2.4% -6.4% 73.9%

FUNDAMENTAL ANALYSIS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Fundamentals Score
[ Q(TTM): Sep2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Valuation Score
[As on : Nov 19,2024 ]

Ratio Standalone
P/E
P/B
P/S
-5.95
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -17.27 Cr
[Latest Qtr - Sep2023 - Standalone Results ]

1.16
P/B Calculated based on Book Value of Rs 88.21 Cr
[Latest Year - Mar2023 - Standalone Results ]

3.88
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2023 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 10% undervalued companies ! Discover More →

FAIR VALUE OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
NA (-ve EV)
1139%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION



BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
-3.05
-12.18
11.56
-1.22
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
NA
-8.69%
-11.38%
-7.22%
-100%
2.94%
-5.43%
1.58%
QtrlyTrend
-3
Latest Qtr: Sep2023
Quarterly Result Analysis →


BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION good for long term investment?

As on Nov 19,2024, the Fundamentals of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION look Poor and hence it may not be good for long term investment ! See Financial Performance of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION UnderValued or OverValued?

As on Nov 19,2024, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?

As on Nov 19,2024, the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Rs. 1.92 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -9.36
Fair Value [Median EV / Sales Model] : Rs. -3.96
Fair Value [Median Price / Sales Model] : Rs. 1.92
Estimated Median Fair Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION : Rs. 1.92

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION trading at a Premium or Discount?

As on Nov 19,2024, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is trading at a Premium of 1139% based on the estimates of Median Intrinsic Value!